The top 10 medical disruptors of 2018


10. Scalp cooling for chemotherapy-related hair loss

scalp cooling for reducing hair loss from chemotherapy

[Image from Cleveland Clinic]

Scalp cooling reduces the temperature of the scalp a few degrees before, during and after chemotherapy. The hair loss prevention system uses cooling fluid to keep the helmet and scalp cold, causing cutaneous vascular constriction while also resulting in reduced biochemical activity. The system also has the potential to reduce cellular uptake of chemotherapy agents and decrease the chances of hair follicles experiencing damage from chemotherapy.

During the clinical trial, 50.5% of patients were able to preserve their hair using the scalp cooling system.

The system was FDA-approved in May 2017 and is starting to become available in hospitals nationwide.

“This is innovative and transformational,” Dr. Alberto Montero, a member of the Cleveland Clinic’s Taussig Cancer Institute, said at this year’s Cleveland Clinic Medical Innovation Summit.

The system does not increase the effectiveness of chemotherapy, according to Montero, but instead constricts the scalp to prevent hair loss.

Next >>

How do you know your technology is disruptive enough to break conventional wisdom?

textadimage Stan Rowe knows a little something about bringing disruptive technology to market. The current Edwards Lifesciences CSO was in on the ground floor of two of medtech's most disruptive treatments, stents and transcatheter aortic valve replacement.

On December 12th, Rowe will sit down with MassDevice editor Brad Perriello for a long ranging discussion about the inside story on how these technologies came to market and what Rowe learned along the way.

Register now with the code "TAVR" and save 15% today.

Pages: 1 2 3 4 5 6 7 8 9 10 11


  1. Very promising disruptions in Healthcare. Will be interested as an incubator to closely track the development of ideas of healthcare startups.

Speak Your Mind